EFA Supplementation May Counteract Depression

July 18, 2005

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


EFA Supplementation May Counteract Depression

TEL AVIV, Israel Depressionmay be associated with an imbalance of essential fatty acids (EFAs) in braincompositionspecifically between arachidonic acid (AA) and the omega-3 EFAs,according to a study published in the June issue of Journalof Lipid Research (46, 6:1093-1096, 2005).

Researchers examined polyunsaturated fatty acid (PUFA)composition in the brains of rats diagnosed with depression and comparedfindings with control rats fed an identical diet. In all brain regions studied, concentration of arachidonicacid (AA) was significantly higher in the depressed rats than in control rats.No significant differences in omega-3 fatty acids or saturated andmonounsaturated fatty acids were observed between depressed and control rats.Researchers concluded both AA and omega-3 fatty acids are important factors inthe pathophysiological processes underlying depression.

The finding that in the depressive rats the omega-3 fattyacid levels were not decreased, but arachidonic acid was substantially increasedas compared to controls is somewhat unexpected, said Pnina Green, M.D.,Ph.D., researcher from the University of Tel Aviv. But the finding lendsitself nicely to the theory that increased omega-3 fatty acid intake may shiftthe balance between the two fatty acid families in the brain, since it has beendemonstrated in animal studies that increased omega-3 fatty acid intake mayresult in decreased brain arachidonic acid.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like